Turkish Journal of Biology
Volume 39

Number 6

Article 10

1-1-2015

The effects of topical melatonin on oxidative stress, apoptosis
signals,and p53 protein expression during cutaneous wound
healing
AZİZE ŞENER
ÖZGE ÇEVİK
ÖZGE DOĞAN
NAZLI GÜL ALTINDİŞ
HALİL AKSOY

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
ŞENER, AZİZE; ÇEVİK, ÖZGE; DOĞAN, ÖZGE; ALTINDİŞ, NAZLI GÜL; AKSOY, HALİL; and OKUYAN, BETÜL
(2015) "The effects of topical melatonin on oxidative stress, apoptosis signals,and p53 protein expression
during cutaneous wound healing," Turkish Journal of Biology: Vol. 39: No. 6, Article 10. https://doi.org/
10.3906/biy-1502-68
Available at: https://journals.tubitak.gov.tr/biology/vol39/iss6/10

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

The effects of topical melatonin on oxidative stress, apoptosis signals,and p53
protein expression during cutaneous wound healing
Authors
AZİZE ŞENER, ÖZGE ÇEVİK, ÖZGE DOĞAN, NAZLI GÜL ALTINDİŞ, HALİL AKSOY, and BETÜL OKUYAN

This article is available in Turkish Journal of Biology: https://journals.tubitak.gov.tr/biology/vol39/iss6/10

Turkish Journal of Biology

Turk J Biol
(2015) 39: 888-895
© TÜBİTAK
doi:10.3906/biy-1502-68

http://journals.tubitak.gov.tr/biology/

Research Article

The effects of topical melatonin on oxidative stress, apoptosis signals,
and p53 protein expression during cutaneous wound healing
1,

2

1

1

1

Azize ŞENER *, Özge ÇEVİK , Özge DOĞAN , Nazlı Gül ALTINDİŞ , Halil AKSOY , Betül OKUYAN
1
Department of Biochemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey
2
Department of Biochemistry, Faculty of Pharmacy, Cumhuriyet University, Sivas, Turkey
3
Department of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, İstanbul, Turkey
Received: 28.02.2015

Accepted/Published Online: 26.05.2015

3

Printed: 31.12.2015

Abstract: Elimination of reactive oxygen species (ROS) can be an important strategy to improve healing of wounds. ROS have an
effect on proliferation and cell survival signaling, which results in alteration of apoptotic pathways in cells. Melatonin has antioxidant
properties on skin wounds. In our study, we investigated the effects of topical melatonin (3%, w/w) on apoptosis and p53 protein
expression together with parameters of oxidative stress in a cutaneous excision wound model. Bcl-2 protein levels in wound tissue at the
end of days 3, 7, and 14 were significantly increased, while caspase-3 activity and p53 protein expression in wound tissue at the end of
days 3, 7, and 14 were also reduced with melatonin treatment during wound healing. On days 3 and 7 after the wound, malondialdehyde
level was reduced and glutathione was increased with melatonin treatment. Melatonin decreased myeloperoxidase levels and increased
hydroxyproline levels in wound tissue at the end of day 7. However, melatonin had no significant effect on percentage of wound closure.
Considering our results, topical melatonin displays antioxidant, antiapoptotic, and p53-inhibitory effects, but these effects are not
sufficient for the acceleration of wound closure.
Key words: Apoptosis, Bcl-2, p53, oxidative stress, topical melatonin, wound healing

1. Introduction
Wound healing is a complex and well-designed repair
process that occurs after any injury, such as surgical
procedures or trauma. The process is divided into three
serial phases: inflammation, tissue formation, and tissue
remodeling (Wu and Chen, 2014). Apoptosis is important
to the wound healing process, especially in removing
inflammatory cells and inhibiting scar formation. The early
phase of inflammation is characterized by the invasion
of neutrophils, macrophages, and lymphocytes to the
wound area. The fibroblasts then migrate and synthesize
extracellular matrix components. Inflammatory cells
must be removed in order to begin this next phase of
wound healing. Remodeling of granulation tissue during
the wound healing process is also accompanied by the
apoptosis of fibroblasts (Rai et al., 2005; Wu and Chen,
2014). Dysregulation in these apoptotic processes may
result in abnormal wound healing, such as hypertrophic
scars and keloid formation (Greenhalgh, 1998), or may
delay wound healing (Deveci et al., 2005; Blakytny and
Jude, 2006). p53 is generally known as a tumor suppressor
and can induce apoptosis via transcription-dependent or
-independent mechanisms (Lippens et al., 2009).
* Correspondence: azizesener@hotmail.com
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Reactive oxygen species (ROS) that arise after
cutaneous injury may worsen the healing process and
induce apoptosis (Hameedaldeen et al., 2014). Low and
normal levels of ROS play important roles in wound
repair and signal transduction for reepithelialization and
proliferation of cells, such as the collagenase activity and
the epidermal growth factor signaling. However, higher
levels of ROS can cause oxidative stress and may damage
intracellular macromolecules such as DNA, lipids, and
proteins. Therefore, regulating oxidative stress and the
inflammatory response is important during the cutaneous
wound healing process (Schäfer and Werner, 2008;
Hameedaldeen et al., 2014). The utilization of antioxidants
has been considered as an effective therapeutic approach
in wound healing (James et al., 2001; Sharifi et al., 2012).
Melatonin
(N-acetyl-5-methoxytryptamine)
is
a hormone produced primarily by the pineal gland
and secreted in the dark during night. It modulates
sleep, reproduction, circadian rhythm, and immunity.
Additionally, melatonin is a potent antioxidant and directly
detoxifies oxygen and nitrogen-based reactants (Reiter et
al., 2003; Sener et al., 2009). It affects the activity and the
levels of cellular mRNA of antioxidant enzymes including
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superoxide dismutase, glutathione peroxidase, and
glutathione reductase (Reiter et al., 2003). Melatonin may
stimulate and regulate gene transcription of these enzymes
via its receptors (Tomas-Zapico and Coto-Montes, 2005).
Melatonin can cross all biological membranes, and thus
it can indicate protective effects against oxidative stress.
Melatonin reaches the nucleus of the cell and protects
essential intracellular structures, including DNA, from
oxidative damage (Fischer et al., 2008a). The human skin
is capable of producing melatonin. Melatonin is involved
in skin functions such as hair growth, pigmentation
physiology, and control of melanoma. Melatonin receptors
(MT1 and MT2) are expressed in different levels depending
on cell types of skin and modified by environmental
factors, such as, exposure to UV radiation (Slominski et
al., 2005).
Novel treatment choices to modify the wound healing
process are being investigated to provide suppression of
inflammation and infection, promotion of the wound
healing process, and prevention of scar formation.
For the investigation of an appropriate therapy to cure
wounds, the evaluation of various factors during the
process of wound healing and their interactions with
each other should be considered. To our knowledge, the
effects of topical melatonin on apoptosis parameters and
p53 protein expression have not been investigated in the
cutaneous excision wound healing process. In the present
study, the effect of topical melatonin on apoptosis (Bcl-2
and caspase-3) and p53 protein expression together with
parameters of oxidative stress has been investigated in a
cutaneous excision wound model.
2. Materials and methods
2.1. Animals
A total of 36 adult Sprague Dawley rats (16 weeks of
age; 250–300 g body mass) of both sexes were obtained
from the Marmara University Experimental Animal
Implementation and Research Center (DEHAMER).
The rats were maintained on a 12/12-h light/dark cycle
and constant temperature (22 ± 1 °C). They were fed
with standard rat chow and were allowed free access to
water, but they were fasted during the 12 h before the
experiment. All procedures for experimental protocols of
the present study were approved by the Marmara School
of Medicine Animal Care and Use Ethical Committee
(protocol number: 14.2013).
2.2. Experimental groups
After wound formation, rats of either sex within each
group were randomly divided into treatment (n = 6) and
control (n = 6) groups and they were placed individually
in separate cages. The study was carried out in three time
periods: days 3, 7, and 14 after wounding.

2.3. Wound model and experimental protocol
Rats were anesthetized by intraperitoneal injection of
ketamine at 10 mg/kg body weight. Hair of the dorsal
surfaces of rats was trimmed with an electrical clipper
before the formation of wounds and cleaned with cleansing
antiseptic solution of chlorhexidine (5 mg/mL). Two
circular wounds were established on the dorsal thoracic
area of each rat by performing full-thickness excisions
using a biopsy punch instrument with 0.6 mm in diameter.
Wounds formation day was accepted as day 0.
Simple ointment (Basiscreme™, Genesis, Turkey) was
applied to the control group and 3% (w/w) melatonin
ointment was applied to the treatment group (~3 mg/
wound), administered to each wound twice a day (Sener
et al., 2006, Ozler et al., 2011) after wound creation during
the experimental periods. Rats were sacrificed at the end
of the experiment under anesthesia with ketamine and
wound tissue samples were collected for the evaluation of
oxidant/antioxidant status, collagen content, and apoptotic
changing. The skin samples were homogenized five times
at 8,000 rpm for 30 s in an MagNA Lyser homogenizer
(Roche Diagnostics GmbH, Germany). Between each
cycle the tubes were set on ice for 2 min.
2.4. Wound closure
Wound contraction is a centripetal movement of the
wound edges towards the center. Sizes of wounds were
measured on days 3, 7, and 14. The shape of each wound
was drawn on transparent paper on days 3, 7, and 14, for
which 1-mm2 graph paper was placed to measure the
wound surface area. The percentage of wound closure was
calculated by using the following formula (Sharifi et al.,
2012):
% of wound closure = (initial wound size – specific day
wound size)/initial wound size) × 100.
2.5. Hydroxyproline assay
To determine collagen synthesis in wound tissues,
hydroxyproline assay was performed according to a
previously described method (Reddy and Enwemeka,
1996). Briefly, wound tissues were homogenized in saline
and then were hydrolyzed with 2 N NaOH for 30 min at
120 °C. After hydrolyzation, samples were blended with
buffer containing chloramine-T reagent and were oxidized
for 20 min at room temperature. The addition of Ehrlich’s
reagent developed a reddish-purple chromophore
complex and absorbance was measured at 550 nm with
a spectrophotometer. Results were expressed as mg
hydroxyproline/g tissue.
2.6. Malondialdehyde and reduced glutathione assays
Wound samples were homogenized with cold 150 mM
KCl buffer in order to measure malondialdehyde (MDA)
and reduced glutathione (GSH) levels. Tissue MDA levels
were measured as thiobarbituric acid (TBA) reactive
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substance formation determining lipid peroxidation as
per a previously described method (Buege and Aust,
1978). Skin homogenates were treated with 1 mL of TBA
reagent and incubated for 15 min in a boiling water bath
and then cooled. The absorbances were measured at 530
nm. Lipid peroxidation was expressed in terms of MDA
equivalents using an extinction coefficient of 1.56 × 105
M–1 cm–1 and results are expressed as nmol MDA/g tissue.
GSH measurements were performed using a modification
of the Ellman procedure (Beutler, 1975). Briefly, after
the precipitation of protein and centrifugation at 1000
× g for 10 min, 0.5 mL of supernatant was added to 2
mL of 0.3 M phosphate buffer, and then 0.2 mL of a
dithiobisnitrobenzoate solution (0.4 mg/mL) was added
and the absorbance at 412 nm was measured. GSH levels
were calculated using an extinction coefficient of 13.600
M–1 cm–1. Results are expressed as µmol GSH/g tissue.
2.7. Myeloperoxidase activity
Myeloperoxidase (MPO) is released by activated
polymorphonuclear leukocytes (PMNs). To assess
accumulation of tissue PMNs in inflamed tissues, MPO
activity is frequently measured (Sener et al., 2006). The skin
MPO levels were determined by the method of Hillegas et
al. (1990). Wound samples were homogenized in 50 mM
potassium phosphate buffer containing 0.5 % hexadecyl
trimethyl ammonium bromide. Samples were frozen and
thawed three times, processed with sonications (10 s, 25
°C), and centrifuged at 41,400 g for 10 min. Supernatant
was mixed with reaction buffer containing o-dianisidine
dihydrochloride and 20 mM hydrogen peroxide (H2O2)
solution in 50 mM phosphate buffer. One unit of MPO
activity was calculated as the change in absorbance at 460
nm for 1 min. Results were expressed as U/g tissue.
2.8. Caspase-3 activity
Determination of caspase-3 activity was performed using
the caspase-3 cellular activity assay kit (Calbiochem, USA)
according to the manufacturer’s protocols. Wound samples
were lysed with cold lysis buffer for 10 min. After the lysis
samples were centrifuged at 10,000 × g for 10 min at 4 °C.
Samples (40 µL) were added to plate wells, and then 50
µL of reaction assay buffer was mixed into each well and
incubated for 10 minutes at 37 °C. A final concentration
of 200 mM acetyl-Asp-Glu-Val-Asp p-nitroanilide (AcDEVD-pNA) substrate was added and incubated for
1–2 h at 37 °C. The colorimetric release of p-nitroaniline
(pNA) from the Ac-DEVD-pNA substrate was measured
at 405 nm using a microplate reader (EPOCH, BioTek
Instruments, Inc., USA). The results were expressed as
nmol pNA/mg protein.
2.9. Western blot analysis for p53 and Bcl-2
The expressions of p53 and Bcl-2 protein were also
measured by western blot. Samples’ protein concentrations
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were determined using the Bradford method (Bradford,
1976). Samples were boiled in 2X Laemmli buffer (Sigma,
USA) and loaded on 12% SDS-PAGE. Nitrocellulose
membrane was used for transferring to protein and
membrane was blocked with 5% milk powder for 2 h at
room temperature. The membrane was then incubated
with primary antibodies (1:500 anti-p53, anti Bcl-2, and
anti-b-actin; Santa Cruz Biotechnology, USA) overnight
at 4 °C and horseradish peroxidase-conjugated secondary
antibody (1:2500; Santa Cruz Biotechnology) was used at
room temperature. The membrane was finally developed
with ECL chemiluminescence reagent and exposed to film.
The samples were quantified using Image J software (NIH,
USA). Signals were normalized with respect to β-actin.
2.10. Statistical analysis
All data from the groups were recorded using GraphPad
Prism 4.0 (GraphPad Software, USA). Two groups
were compared with Mann–Whitney U tests. Results
are expressed as means ± standard deviation (SD). The
differences were considered significant at P < 0.05.
3. Results
3.1. Wound closure and hydroxyproline formation
On days 3, 7, and 14, there was a difference in percentage
of wound contraction between the control and melatonin
groups (Figures 1A and 1B). These differences were not
significant (P > 0.05). After day 14 of injury, wound closure
in the melatonin group was 98%. The control group had
94% wound closure. Melatonin did not significantly
accelerate the wound closure rate in normal rats.
At the end of day 7, the hydroxyproline content in
granulation tissue was significantly increased in the
melatonin treatment group versus the control group (P
< 0.05) (Figure 2A). On days 3 and 14, no significant
difference was detected in hydroxyproline levels between
the two groups.
3.2. Oxidative stress markers
At the end of days 3 and 7, MDA levels were significantly
reduced in the melatonin treatment group (Figure 2B, P <
0.05). At the end of day 14, MDA levels of the melatonintreated group were similar to those of the control group
rats.
At the end of days 3 and 7, GSH levels were significantly
increased in the melatonin treatment group (Figure 2C, P
< 0.05). At the end of day 14, GSH values in the melatonin
group were higher than in the control group, but this
increase was not statistically significant (P > 0.05).
Melatonin also significantly reduced MPO levels
compared to the control group on day 7 (Figure 2D, P <
0.05). At the end of day 14, MPO levels of the melatonin
group were near the control levels.
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Figure 1. (A) The percent of wound closure in control and melatonin groups
(MEL) at different days. (B) Photographic representation of closure rate in
control and melatonin groups in different time periods.

3.3. Apoptosis markers and p53 protein expression
The level of apoptosis in the wound tissue of control rats
was greater than that in the wound tissue of melatonintreated rats. Topical melatonin decreased the level of
apoptosis after skin injury (Figure 3). As shown in Figure
3A, caspase-3 activity was significantly reduced on days 3
and 7 in the group treated with melatonin (P < 0.05 and
P < 0.001, respectively). At the end of day 14, caspase-3
activity measurements of the melatonin group were still
lower than those of control rats (P < 0.001). Bcl-2 and p53
protein expression were determined by western blotting.
Figure 3B represents the western blot images of control
and melatonin groups. The expression of Bcl-2 protein
was significantly upregulated at the end of day 3 and 7
(Figure 3C), whereas the expression of p53 protein was
significantly downregulated at the end of days 3, 7, and
14 in the melatonin-treated wounds when compared with
those in the control wounds (Figure 3D). On days 3, 7, and
14, Bcl-2/p53 was 0.96 ± 0.02, 0.56 ± 0.03, and 1.03 ± 0.13
in the control group and 2.04 ± 0.03, 2.84 ± 0.3, and 1.67

± 0.47 in the treatment group (data not shown in figures).
According to these results, Bcl-2/p53 was markedly
increased on day 7 after the administration of melatonin.
4. Discussion
Topical administration of melatonin in wound healing
has been investigated in different wound models
(Drobnik, 2012). Most studies pointed out that the effect
of melatonin on wound healing was dependent on the
type of wound model and the route, dosage, and time of
administration (Drobnik and Dabrowski, 1996; Drobnik,
2012). Pinealectomy, which decreases melatonin level in
the blood, has been found to reduce the surface area of
the wound and accelerate wound repair (Drobnik and
Dabrowski, 1996). Bulbuller et al. (2005) observed that
subcutaneous melatonin application decreased collagen
synthesis and epithelium proliferation and indicated
undesirable effects on incision and anastomotic wound
healing in normal and pinealectomized rats. However,
positive improvement in the wound healing process

891

ŞENER et al. / Turk J Biol

Figure 2. (A) Hydroxyproline, (B) malondialdehyde (MDA), (C) reduced glutathione (GSH) levels, and (D)
myeloperoxidase (MPO) activity in the wounds of control and melatonin (MEL)-treated rats. Results are
presented as mean ± SD. *: P < 0.05 versus control group.

Figure 3. (A) Caspase-3 activity in the wound tissue of control and melatonin-treated rats. (B) Representative western blot
images of groups. (C) Expressions of Bcl-2 and (D) p53 protein in the wounded tissue of control and melatonin (MEL)treated rats. *: P < 0.05, **: P < 0.01, ***: P < 0.01 versus control groups.

892

ŞENER et al. / Turk J Biol

has been detected due to topically and systematically
administered melatonin on chronic wound healing in rats
with pinealectomy (Ozler et al., 2010) and also on pressure
ulcer in rats (Sener et al., 2006).
Melatonin has oncostatic and antimitotic properties
(Viswanathan and Schernhammer, 2009) and systemic
administration of melatonin may affect many tissues.
However, melatonin’s limited access to skin would be
expected after systematic administration of melatonin.
Melatonin with topical application can penetrate into
the stratum corneum, where it accumulates because of
its marked lipophilic chemical structure (Tomas-Zapico
and Coto-Montes, 2005). Therefore, in the present study,
melatonin was administered topically two times daily
(morning and evening). In our study, although topical
melatonin increased hydroxyproline content on day 7
in skin, when compared with the control and treatment
group on day 14, a similar wound closure rate was detected
in both groups. Melatonin did not delay wound healing at
day 14, but on the other hand, it did not markedly provide
acceleration in wound closure, either.
Management of inflammation and oxidation is crucial
during the process of wound healing. Although ROS in low
and normal levels can be involved in regulation of repair,
excessive formation of ROS may lead to postponed wound
healing by the means of destruction of lipids, proteins,
and extracellular matrix elements (Hameedaldeen et al.,
2014). The positive effect of antioxidants on cutaneous
wound healing via inhibition of ROS has been presented
in several studies (James et al., 2001; Reiter et al., 2003;
Sharifi et al., 2012). In the present study, when compared
with control group, topical administration of melatonin
provided suppression of MDA levels in injured skin while
increasing GSH levels.
Endogenous melatonin may have antiinflammatory
effects (Cuzzocrea et al., 1999). In our study, skin injury
caused increase in MPO activity, an index of PMN
accumulation, while treatment with topical melatonin
caused reductions in MPO activity on day 7. Increased
MPO activity in wound tissue suggests neutrophil
accumulation and contributes markedly to tissue damage
(Sener et al., 2006). Ozler et al. (2011) showed that topically
applied melatonin (5 mg/kg) in ischemic wounds had
neither a positive nor a negative effect on hydroxyproline
levels. However, it showed antioxidant efficacy through
decreasing MDA levels (Ozler et al., 2011). Although
melatonin was administered at an amount of 3 mg per
wound in the present study, in the study conducted
by Ozler et al. (2011), melatonin was administered at
an amount of 0.1 mg per wound. Similar to our results,
topical administration of melatonin (5 mg melatonin per
rat and twice a day) decreased both MDA and MPO level
in injured skin in rats with pressure ulcers (Sener et al.,

2006). According to results shown in the present study,
topically administered melatonin could suppress oxidative
stress and inflammation in the wound tissue.
In the present study, caspase-3 activation and Bcl-2
and p53 protein expression were detected as apoptotic
markers. Apoptosis occurs through several independent
pathways that are initiated by diverse extracellular (via
death receptor) and intracellular factors. The intrinsic
pathway centers on the mitochondria, which contain
key apoptotic factors. One of the major regulators of the
intrinsic pathway is the pro- and antideath member, the
Bcl-2 family. Bcl-2 regulates mitochondrial physiology
and caspase activation (Lippens et al., 2009). Caspases
are a family of cysteine proteases that play essential
roles in apoptosis. Caspase-3 is a key factor in apoptosis
execution and a point of junction for the intrinsic and
extrinsic apoptotic pathways (Fan et al., 2005). p53 acts
to integrate multiple stress signals into a series of diverse
antiproliferative responses and can induce apoptosis.
Cytoplasmic p53 can bind directly to several antiapoptotic
members of the Bcl-2 superfamily by neutralizing their
antiapoptotic activity (Lippens et al., 2009).
The increase in ROS would also induce apoptotic
processes during wound healing. It was stated that
enhancement in apoptosis in injured skin would also
explain the problems seen during wound healing in
diabetes mellitus (Blakytny and Jude, 2006). Deveci et
al. (2005) observed that augmentation in oxidative stress
would also increase apoptosis of keratinocytes when
cultured in hyperglycemic media, indicating delayed
wound healing when compared to normoglycemic media.
It has been shown that melatonin has differential
actions on apoptosis in normal and cancer cells (Sainz et
al., 2003). In most studies, it was shown that melatonin
possessed antiapoptotic effects on normal skin cells.
However, other studies focused on isolated cell populations
and UV or thermal-induced skin injury (Fischer et al.,
2008b; Kim et al., 2001). In one in vivo study, melatonin
maintained muscle restoration after muscle injury and
inhibited apoptosis through regulation of apoptosisrelated signaling pathways (Stratos et al., 2012). Studies on
Bcl-2 and p53 protein expression in wounded tissue were
observed and it was found that there was a negative relation
between levels of Bcl-2 and p53 protein in normal wound
healing processes. Nagata et al. (1999) followed apoptosis
and p53 protein expression in full-thickness burn wounds
of guinea pigs from 0.5 to 28 days. It was observed that
apoptosis and p53 protein expression rose in both the
inflammatory (0.5–2 days) and proliferation (2–14 days)
stages of wound healing, but apoptosis and p53 protein
expression diminished during the remodeling stage (14–
28 days). Kane and Greenhalgh (2000) also observed that
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there was an increase in Bcl-2 and a decrease in p53, which
allows cellular proliferation for tissue repair after injury. As
time passes, Bcl-2 levels decrease while p53 levels increase
to end the inflammatory process and downregulate
the proliferative response. According to researchers, in
diabetic mice, this negative relationship between Bcl-2 and
p53 may be lost. However, it was reported that inhibition
of p53 would also improve wound healing. Vollmar et
al. (2002) demonstrated that pifithrin-α (PFT-α) could
transiently inhibit p53. This results in acceleration of early
epithelization and neovascularization during cutaneous
wound healing by promoting leukocytes, increasing cell
proliferation, and reducing apoptotic cell death.
Similar to previous studies, our study also observed
that the Bcl-2 protein expression in the control group
had a negative relation with p53 protein expression. After
injury, the expression of p53 protein increased while the
expression of Bcl-2 reduced on day 7. The expression of
Bcl-2 increased on day 14 when compared to Bcl-2 levels
on day 7. Adherence to inverse association between
levels of Bcl-2 and p53 protein was also seen on day 14,
and decrease in levels of p53 protein was observed when
compared with p53 protein levels on day 7.
Melatonin markedly reduced the expression of p53
protein when compared with the control group, and
the expression of p53 protein levels remained close to
each other in the melatonin group on days 3, 7, and
14. In this way, melatonin caused deterioration of the
negative relationship observed between Bcl-2 and p53
during the normal wound healing process. Increase in
ROS can also cause downregulation of Bcl-2 (Chang et

al., 2002). According to results obtained in the present
study, melatonin detoxified ROS and inhibited apoptosis
by reversing the decline in oxidative stress induced Bcl-2
levels. In the present study, after injury occurred, activation
of caspase-3 was increased on day 7. However, activation of
caspase-3 was decreased on day 14. Melatonin caused the
upregulation of Bcl-2 protein on days 3 and 7. Melatonin
also markedly inhibited the activation of caspase-3. This
decrease in activation of caspase-3 could be explained by
upregulation of Bcl-2 by melatonin. It has been also shown
that melatonin suppresses caspase-3 activity via Bcl-2
induction in several cell types (Yoo et al., 2002; Baydas et
al., 2005).
In conclusion, the evidence of apoptosis was decreased
by melatonin via the downregulation of expression of
p53 and detoxification of ROS in injured skin tissue.
Although effects such as antiapoptosis and inhibition of
p53 of melatonin were demonstrated in the results of the
present study, melatonin could not significantly accelerate
wound closure in our study conditions. Further studies
should be planned to define the associations among the
suppression of p53 expression, the reduction of apoptotic
cell death, and wound closure with topical administration
of melatonin.
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